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Abstracts / Urological Science 27 (2016) S53eS83 S67review. ne was 35.04 ± 22.24gm. The mean PSA level was 12.69± The m,
and two cases of prostate adenocarcinoma were found. The mean opera-
tive time was 111.83± and t minutes, and 25.11±minutesgm of specimen
was collected. The mean days of hospital stay was 5.69±m3.02 days, and
5.29± days, and 5.29 as collected. The mean days of hospital stay was 5.69
ive time was 111.83 ted with a o post-op blood transfusion was given. No
post-op urine retention was noted. The resected weight of prostate is
larger than previous 2 groups, however, length of hospital stay is not
signiﬁcant among the 3 groups.
Conclusion: The new laser modality, MultiPulse® Tm+1470 laser, is
available for TUR-P, and the result is comparable with previous laser
prostatectomy. Further study with larger patients group and long-term
follow-up is mandutory.
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Purpose: The aim of this study is to investigate the risk of diabetesmellitus
(DM) after 5-alpha-reductase inhibitor (5ARI) therapy for benign prostate
hyperplasia (BPH) using the National Health Insurance Research Database
(NHIRD) in Taiwan.
Materials and Methods: In total, 1298 adult patients newly diagnosed
with BPH and who used more than 28 cumulative deﬁned daily doses
(cDDD) of 5ARI were recruited as the therapy group cohort, along with
12887 subjects who did not use more than 28 cDDD of 5ARI as a control
group from 2002 to 2009. Each patient was monitored for ﬁve years (from
2003 to 2008) to identify those who subsequently developed DM. A Cox
proportional hazards model was used to compare the risk of DM between
the study and comparison cohorts after adjusting for possible confounding
risk factors.
Results: Patients who received 5ARI therapy had a lower cumulative rate
of DM than those who did not receive 5ARI during the ﬁve-year follow-up
period (3.5% vs. 5.3%, p¼ 0.003). In sub-group analysis, among the BPH
patients aged <65 years, the ﬁve-year DM events hazard ratio (HR) of 5ARI
users was lower than that of non-users (HR: 0.47, 95% conﬁdence interval
(CI): 0.24e0.91; p¼ 0.026).
Conclusion: Therapy with 5ARI may decrease the ﬁve-year risk of DM in
the BPH patients younger than 65 years. Further mechanistic research is
warranted to validate the results.
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THE TOLERANCE OF TAMSULOSIN 0.4MG (HARNALIDGE® OCAS®) IN
MANAGING BENIGN PROSTATE OBSTRUCTION IN TREATMENT-NAIVE
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Buddhist Tzu Chi University, Hualien, Taiwan
Purpose: In Taiwan, the recommended initial dosage of tamsulosin for
managing men’s lower urinary tract symptoms (LUTS) is 0.2mg per day.
The aim of the study is to evaluate the tolerance of tamsulosin 0.4mg
(Harnalidgelien, Taiwan.te the results.3). In sub-group analysis, among the
BPH patients aged <65 ye.
Material and Methods: From 2015 Jan to 2015 Dec, we retrospectively
reviewed men with LUTS suggestive of BPO visiting urologic clinics
without previous exposure to alpha blockers or 5-alpha reductase for
study. Exclusion criteria were those with urethral stricture, previous
prostate surgery, chronic kidney disease under dialysis, acute urine
retention under urethral catheterization and prostate or bladder cancer.
Baseline patient characteristics including age, international prostatic
symptom score (IPSS), total prostate volume, uroﬂowmetry and post-void
urine volume were recorded.
Results: Finally, 194 alpha-blockers naive men (mean age¼ 70.5± 14.2
years) were enrolled for analysis with. The baseline IPPS, prostate size,Qmax, PVR was 13.9± 6.3 points, 53.9± 22.8 gm, 11.5± 4.7 ml/sec, and
39.4± 33.2 mL respectively. There were only 4 shifted to the other alpha
blockers (2 silodosin and 1 tamsulosin 0.2 mg due to side effects and 1
doxazosin due to poor effect) with a mean follwup of 137± 181 days. The
Qmax and PVR improved to 12.8± 5.5 ml/sec (p¼ 0.08) and
36.2± 46.1 ml (p¼ 0.65) at 3 months followups while not statistically
signiﬁcant.
Conclusion: Tamsulosin 0.4 mg is well tolerated in alpha-blcokers na2
years) were enrolled for analysis with. The baseline IPPS, prostate size,
Qmax, PVR was 13AS® is not warranted in Taiwanese men.
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Purpose: Nocturia is one of the most distressing symptoms in older men
with benign prostatic hyperplasia and is the lower urinary tract symptom
most strongly associated with poor quality of life ratings. It is associated
with increased rates of depression, work absenteeism, lower self-rated
physical and mental health, congestive heart failure, and increased all-
cause mortality. Nocturia is was noted to have higher rates of accidental
falls and fractures in the very old. There are many factors associated with
nocturia and and treatment may result in only small improvement. We
examined the prevalence of and risk factors for nocturia in North down-
town, Kaohsiung City.
Materials and Methods: We collected data on 1629 individuals with 1142
males and 487 females who living at North downtown, Kaohsiung City. We
analyze the relationships between nocturia assessed by a questionare and
other variables including age, blood pressure, Cardiovascular disease, ce-
rebrovascular disease, COPD, DM, Chronic renal failure, BPH, smoking habit
and alcohol intake.
Results: Overall, 493 individuals (30.3%) answered that they arose to
urinate at least twice during the night. The rate increased with age from
18.7 % in individuals younger than 50 to 56% in those older than 69. Logistic
regression analysis revealed that cohorts of subjects 50e59, 60e69, and 70
years old or over had, respectively, 1.82, 3.43, 5.88times the prevelance of
nocturia of the 49 years or younger cohort. Hypertention (OR 2.04), DM
(OR 1.87) and heavy smoking habit (OR 1.66) were other independent
positive factors for nocturia. In male individuals, BPH was another inde-
pendent positive risk factor (OR 1.57). Gender was not associated with
nocturia.
Conclusion: Nocturia may be caused by conditions or disorders that result
in low bladder volume voids, nocturnal polyuria, or sleep disturbances.
Age, benign prostatic hyperplasia, congestive heart failure, renal disease,
diabetes mellitus, and Hypertension are some of the conditions associated
with nocturia. Because nocturia is associated with a variety of clinical
syndromes and disorders, the diagnostic approach is often challenging,
and treatment may result in only small improvement.
Urolithiasis
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A DIFFICULT URETER STONE, IN A PATIENT WITH ILEAL CONDUIT AND
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Introduction and Case Report: The two most common forms of ureter-
oenteric anastomosis after radical cystectomy and urinary diversion are the
Bricker (separate) and Wallace (conjoined) techniques. The choice usually
depends on the surgeon’s preference and experience. Reports had sug-
gested higher stricture rates with the Bricker and increased risks for bilat-
eral renal obstruction with the Wallace. On account of the difﬁculty of the
procedure, ome experts suggested it is easier to perform Bricker methods
for ureteroenteric anastomosis in patients with high body mass index.
